Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2022) 81 P95 | DOI: 10.1530/endoabs.81.P95

1Taher Sfar University Hospital, Endocrinology Department, Moknine, Tunisia; 2Taher Sfar University Hospital, Endocrinology Department, Mahdia, Tunisia; 3Taher Sfar University Hospital, Endocrinology Department, Mahdia, Tunisia; 4Taher Sfar University Hospital, Endocrinology Department; 5Taher Sfar University Hospital, Endocrinology Department, Moknine, Tunisia; 4Taher Sfar University Hospital, Endocrinology Department, Tunisia


Introduction: Diabetes stigma (DS) refers to the experience of negative feelings such as exclusion, blame, rejection, or judgment due to having a chronic disease. The objective of this work was to measure the DS and its clinical determinants in type 2 diabetic patients.

Patients and methods: Cross-sectional study conducted on 84 type 2 diabetic patients who consulted on an outpatient basis between September and December 2021. DS was assessed using the arabic version of the type 2 Diabetes Stigma Assessment Scale (DSAS-2).

Results: Women represented 42% of the patients. The duration of diabetes was meanly 9.4±6.4 years. The mean glycated hemoglobin was 9.9 % ±2.4. The mean BMI was 27.7 Kg/m2±4.7. The mean Total Diabetes Stigma score was 46.9 ±10.2 (range 19– 90). Subscale scores were as follows: Treated differently: 15.4±4.2 (range 6– 30), Blame and Judgment: 17.5 ±4.3 (range 7– 35), and Self stigma: 13.9±2.3 (range 6– 30). A total of 26 (30%) respondents scored more than the mean total diabetes stigma score, suggestive of potentially problematic perceived diabetes stigma. Higher Total Diabetes Stigma Scores were associated with level of therapeutic education (P=0,045), social coverage (P=0,043), diabetes treatment (P=0,044), HbA1c level (P=NS).

Discussion and conclusion: The results of this work highlights the importance of identifying DS in type 2 diabetics. High levels of DS have been associated with poor glycemic control, poor diabetes self-management and poor quality of life. These data support the need to focus on increasing awareness efforts to educate the public about type 2 diabetes and its management.

Volume 81

European Congress of Endocrinology 2022

Milan, Italy
21 May 2022 - 24 May 2022

European Society of Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches.

My recently viewed abstracts